Milan: bullish cue from Pharmanutra
(Teleborsa) - The Pharmaceutical company specialized in the development of nutraceutical supplements and medical devices achieves a significant increase, gaining +3.54% on previous levels.On a weekly basis, the stock is trending higher than the FTSE Italia Mid Cap. The performance of Pharmanutra, in fact, has been higher than the related benchmark index.
The technical status of Pharmanutra shows that the security's performance is increasing in the short term, with the first resistance area identified at the 55.9 Euros level. There is the risk of a possible correction towards the target of 55. Yet, we expect a rise of the bullish trend line towards the resistance area at 56.8.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 10-09-2024 09:35